Clincosm LogoSign in Get a demo

tumor, solid

Showing 26 - 41 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor, Solid Trial in United States (BDB001, Atezolizumab)

Active, not recruiting
  • Tumor, Solid
  • Los Angeles, California
  • +4 more
Jul 6, 2022

Tumor, Solid, Positron-Emission Tomography, Colorectal Cancer Trial in Beijing (18F-FDG and 68Ga-DOTA-FAPI04 PET/CT, 18F-FDG and

Recruiting
  • Tumor, Solid
  • +2 more
  • 18F-FDG and 68Ga-DOTA-FAPI04 PET/CT
  • 18F-FDG and 18F-DOTA-FAPI04 PET/CT
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jun 24, 2022

Tumor, Solid Trial in Xiamen (68Ga-DOTA-hLAG-3 PET/CT)

Recruiting
  • Tumor, Solid
  • 68Ga-DOTA-hLAG-3 PET/CT
  • Xiamen, Fujian, China
    The First affiliated hospital of xiamen university
May 8, 2022

Cancer, Tumor, Solid Trial in London ([18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid), PET/CT)

Recruiting
  • Cancer
  • Tumor, Solid
  • [18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid)
  • PET/CT
  • London, United Kingdom
  • +2 more
Mar 2, 2022

Tumor, Solid, Gall Bladder Cancer, Cervical Cancer Trial in Santiago, Vina del Mar (Andes-1537 for Injection)

Completed
  • Tumor, Solid
  • +5 more
  • Andes-1537 for Injection
  • Santiago, Region Metropolitana, Chile
  • +3 more
Feb 23, 2022

Cancer, Tumor, Solid, Refractory Cancer Trial in Los Angeles, Petach Tikva (TBX-3400)

Recruiting
  • Cancer
  • +2 more
  • TBX-3400
  • Los Angeles, California
  • +1 more
Feb 1, 2022

Tumor, Solid Trial in Essen (68Ga-FAPI-46 PET Scan)

Recruiting
  • Tumor, Solid
  • 68Ga-FAPI-46 PET Scan
  • Essen, NRW, Germany
    Department of Nuclear medicine, University hospital Essen
Dec 15, 2021

Tumor, Solid Trial in United States (BDB001, Pembrolizumab)

Active, not recruiting
  • Tumor, Solid
  • Sarasota, Florida
  • +4 more
Nov 30, 2021

Tumor, Solid Trial in Morristown, Houston (BDB001)

Active, not recruiting
  • Tumor, Solid
  • Morristown, New Jersey
  • +1 more
Nov 9, 2021

Cancer, Tumor, Solid, Malignant Tumor Trial in Scottsdale, Austin, San Antonio (OR2805, Pembrolizumab, Nivolumab)

Recruiting
  • Cancer
  • +8 more
  • Scottsdale, Arizona
  • +2 more
Oct 15, 2021

Chemical Pattern Exhaled by Different Neoplasms Through

Recruiting
  • Tumor, Solid
  • blood analysis with SCENT B1
  • tissue analysis with SCENT B1
  • Ferrara, Italy
    Istituto di chirurgia generale 1
Sep 29, 2021

Tumor, Solid Trial in Lexington (Durvalumab and Tremelimumab)

Recruiting
  • Tumor, Solid
  • Durvalumab and Tremelimumab
  • Lexington, Kentucky
    Markey Cancer Center
Aug 19, 2021

Tumor, Solid Trial in Sarasota, Grand Rapids (BDB018, Pembrolizumab)

Recruiting
  • Tumor, Solid
  • Sarasota, Florida
  • +1 more
Jul 30, 2021

Actual Patient Care Site Two Months After Hospitalisation

Completed
  • Hematologic Malignancy
  • Tumor, Solid
    • Strasbourg, France
      Institut de Cancerologie Strasbourg Europe
    Jan 29, 2021

    Tumor, Solid, Lymphoma Trial in Beijing (GR1405 injection)

    Unknown status
    • Tumor, Solid
    • Lymphoma
    • GR1405 injection
    • Beijing, China
      Cancer Institute/Hospital, Chinese Academy of Medical Sciences &
    Nov 4, 2018

    Tumor, Solid, Cancer, Metastatic, Tumor Malignant Trial (SHR9146+SHR-1210, SHR9146+SHR-1210+Apatinib)

    Unknown status
    • Tumor, Solid
    • +2 more
    • (no location specified)
    Jun 2, 2018